Clinical Trials

In direct support of the White House and CMS’s bold initiative to “Make Health Tech Great Again,” Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology. With its Patient Connect app and intelligent assistant DrArturoAI already live and serving patients,…

– Clinical study confirms safety, feasibility, and tolerability of the Everads Injector– – Preclinical data demonstrate the feasibility of in-office, minimally invasive suprachoroidal buckling using the Everads Injector to repair retinal detachments –  Everads Therapy, a clinical-stage company leveraging its novel suprachoroidal delivery technology to advance the treatment of retinal diseases, today announced two oral presentations…

Kwame Marfo brings more than 15 years of experience at the intersection of life sciences, health technology, and product innovation Unlearn®, a leader in AI solutions for clinical trials, today announced the appointment of Kwame Marfo as its Vice President of Product. Marfo’s appointment solidified Unlearn’s trajectory, as it continues to scale and advance its…

Powering Alzheimer’s research with AI-driven insights across cognition, meaning, motor function, and speech — accelerating study recruitment and enabling more equitable, personalized brain health care Linus Health, which is revolutionizing brain health with science-driven digital solutions, will present two oral presentations and eight posters at the Alzheimer’s Association International Conference® (AAIC®) 2025, taking place July 27-31 in Toronto and virtually. Linus Health…

Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases. This effort, known as the Louisiana AI Drug Development Infrastructure for ALS (LADDIA), brings together leading institutions and innovators, including GATC Health, Pennington Biomedical Research Center, and Tulane University —  a tech-bio innovator…

Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to stall momentum. As biopharmaceutical companies double down on innovation and patient-centric research, a new industry survey from studioID and TriNetX reveals widespread integration of RWD and AI in drug development…

Expands use of the Certara Pinnacle 21® (P21) enterprise software platform to optimize clinical data flows for speed and quality Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of the United States and Canada, that expands Merck’s use of the Certara…